119 related articles for article (PubMed ID: 38566526)
21. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
[TBL] [Abstract][Full Text] [Related]
22. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
23. NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Ferrara G; Errede M; Girolamo F; Morando S; Ivaldi F; Panini N; Bendotti C; Perris R; Furlan R; Virgintino D; Kerlero de Rosbo N; Uccelli A
Acta Neuropathol; 2016 Jul; 132(1):23-42. PubMed ID: 27026411
[TBL] [Abstract][Full Text] [Related]
24. ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.
Lyck R; Lécuyer MA; Abadier M; Wyss CB; Matti C; Rosito M; Enzmann G; Zeis T; Michel L; García Martín AB; Sallusto F; Gosselet F; Deutsch U; Weiner JA; Schaeren-Wiemers N; Prat A; Engelhardt B
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2894-2909. PubMed ID: 28273717
[TBL] [Abstract][Full Text] [Related]
25. TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis.
Döring A; Pfeiffer F; Meier M; Dehouck B; Tauber S; Deutsch U; Engelhardt B
Eur J Immunol; 2011 Mar; 41(3):813-21. PubMed ID: 21341265
[TBL] [Abstract][Full Text] [Related]
26. Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.
Lécuyer MA; Saint-Laurent O; Bourbonnière L; Larouche S; Larochelle C; Michel L; Charabati M; Abadier M; Zandee S; Haghayegh Jahromi N; Gowing E; Pittet C; Lyck R; Engelhardt B; Prat A
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E524-E533. PubMed ID: 28069965
[TBL] [Abstract][Full Text] [Related]
27. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.
Crocker SJ; Whitmire JK; Frausto RF; Chertboonmuang P; Soloway PD; Whitton JL; Campbell IL
Am J Pathol; 2006 Dec; 169(6):2104-16. PubMed ID: 17148673
[TBL] [Abstract][Full Text] [Related]
28. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
[TBL] [Abstract][Full Text] [Related]
29. Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.
Horng S; Therattil A; Moyon S; Gordon A; Kim K; Argaw AT; Hara Y; Mariani JN; Sawai S; Flodby P; Crandall ED; Borok Z; Sofroniew MV; Chapouly C; John GR
J Clin Invest; 2017 Aug; 127(8):3136-3151. PubMed ID: 28737509
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
[TBL] [Abstract][Full Text] [Related]
31. Disruption of central nervous system barriers in multiple sclerosis.
Alvarez JI; Cayrol R; Prat A
Biochim Biophys Acta; 2011 Feb; 1812(2):252-64. PubMed ID: 20619340
[TBL] [Abstract][Full Text] [Related]
32. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis.
McCandless EE; Budde M; Lees JR; Dorsey D; Lyng E; Klein RS
J Immunol; 2009 Jul; 183(1):613-20. PubMed ID: 19535637
[TBL] [Abstract][Full Text] [Related]
33. Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system.
Chen Q; Liu Y; Lu A; Ni K; Xiang Z; Wen K; Tu W
J Autoimmun; 2017 Feb; 77():1-10. PubMed ID: 28341037
[TBL] [Abstract][Full Text] [Related]
34. Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis.
Tezuka K; Suzuki M; Sato R; Kawarada S; Terasaki T; Uchida Y
J Neurochem; 2022 Mar; 160(6):662-674. PubMed ID: 35064931
[TBL] [Abstract][Full Text] [Related]
35. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
36. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
[TBL] [Abstract][Full Text] [Related]
37. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
Front Immunol; 2021; 12():792465. PubMed ID: 34975892
[TBL] [Abstract][Full Text] [Related]
38. 2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Choi BY; Sim CK; Cho YS; Sohn M; Kim YJ; Lee MS; Suh SW
Neurosci Lett; 2016 Aug; 628():78-84. PubMed ID: 27297771
[TBL] [Abstract][Full Text] [Related]
39. Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory.
Arima Y; Kamimura D; Sabharwal L; Yamada M; Bando H; Ogura H; Atsumi T; Murakami M
Mediators Inflamm; 2013; 2013():898165. PubMed ID: 23990699
[TBL] [Abstract][Full Text] [Related]
40. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.
Bittner S; Ruck T; Schuhmann MK; Herrmann AM; Moha ou Maati H; Bobak N; Göbel K; Langhauser F; Stegner D; Ehling P; Borsotto M; Pape HC; Nieswandt B; Kleinschnitz C; Heurteaux C; Galla HJ; Budde T; Wiendl H; Meuth SG
Nat Med; 2013 Sep; 19(9):1161-5. PubMed ID: 23933981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
